Saravanakumar Rajendran

Dr. Saravanakumar Rajendran

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2014 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
SRSaravanakumar Rajendran
Saravanakumar Rajendran
RRRamya Raghunathan
Ramya Raghunathan
IHIvan Hevus
Ivan Hevus
RKRetheesh Krishnan
Retheesh Krishnan
AUAngel Ugrinov
Angel Ugrinov
JSJayaraman Sivaguru
Jayaraman Sivaguru

15 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
HBHari Deva Muthu B
Hari Deva Muthu B
TMTamilvelan Manjunathan
Tamilvelan Manjunathan
CACarlton Ranjith Wilson Alphonse
Carlton Ranjith Wilson Alphonse
SRSaravanakumar Rajendran
Saravanakumar Rajendran
TSThanigaivel Sundaram
Thanigaivel Sundaram
Stefano BellucciStefano Bellucci
Stefano Bellucci
In this study, we speculate that the hydroxyl-containing benzo[b]thiophene analogs, 1-(3-hydroxybenzo[b]thiophen-2-yl) ethanone (BP) and 1-(3-hydroxybenzo[b]thiophen-2-yl) propan-1-one hydrate (EP), might possess antiproliferative activity against cancer cells. Hydroxyl-containing BP and EP show selectivity towards laryngeal cancer cells (HEp2), with IC50 values of 27.02 ± 1.23 and 35.26 ± 2.15 µM, respectively. The hydroxyl group present in the third position is responsible for the anticancer activity and is completely abrogated when the hydroxyl group is masked. BP and EP enhance the antioxidant enzyme activity and reduce the ROS production, which are correlated with the antiproliferative effect in HEp-2 cells. An increase in the BAX/BCL-2 ratio occurs during the BP and EP treatment and activates the caspase cascade, resulting in apoptosis stimulation. It also arrests the cells in the Sub-G1 phase, indicating the induction of apoptosis. The molecular docking and simulation studies predicted a strong interaction between BP and the CYP1A2 protein, which could aid in combinational therapy by enhancing the bioavailability of the drugs. BP and EP possess an antioxidant property with low antiproliferative effects (~5.18 µg/mL and ~7.8 µg/mL) as a standalone drug, therefore, they can be combined with other drugs for effective chemotherapy that might trigger the effect of pro-oxidant drug on healthy cells.


1 February 2019 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
SMSubramani Muthuraman
Subramani Muthuraman
SSShweta Sinha
Shweta Sinha
CVC.S. Vasavi
C.S. Vasavi
KWKamran Waidha
Kamran Waidha
BBBiswarup Basu
Biswarup Basu
SRSaravanakumar Rajendran
Saravanakumar Rajendran

18 July 2024 in Biofilm
Verified
Journal Article
Open access
YKYael Kadosh
Yael Kadosh
SMSubramani Muthuraman
Subramani Muthuraman
KNKhairun Nisaa
Khairun Nisaa
ABAnat Ben-Zvi
Anat Ben-Zvi
DBDanit Lisa Karsagi Byron
Danit Lisa Karsagi Byron
AKAriel Kushmaro
Ariel Kushmaro
Bacterial communication, Quorum Sensing (QS), is a target against virulence and prevention of antibiotic-resistant infections. 16 derivatives of Piperlongumine (PL), an amide alkaloid from Piper longum L., were screened for QS inhibition. PL-18 had the best QSI activity. PL-18 inhibited the lasR-lasI, rhlR-rhlI, and pqs QS systems of Pseudomonas aeruginosa. PL-18 inhibited pyocyanin and rhamnolipids that are QS-controlled virulence elements. Iron is an essential element for pathogenicity, biofilm formation and resilience in harsh environments, its uptake was inhibited by PL-18. Pl-18 significantly reduced the biofilm biovolume including in established biofilms. PL-18-coated silicon tubes significantly inhibited biofilm formation. The transcriptome study of treated P. aeruginosa showed that PL-18 indeed reduced the expression of QS and iron homeostasis related genes, and up regulated sulfur metabolism related genes. Altogether, PL-18 inhibits QS, virulence, iron uptake, and biofilm formation. Thus, PL-18 should be further developed against bacterial infection, antibiotic resistance, and biofilm formation.

1 January 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
NNNatarajan Nandakumar
Natarajan Nandakumar
SMSubramani Muthuraman
Subramani Muthuraman
PGPushparathinam Gopinath
Pushparathinam Gopinath
PNPattusamy Nithya
Pattusamy Nithya
JGJacob Gopas
Jacob Gopas
SRSaravanakumar Rajendran
Saravanakumar Rajendran